XML 49 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Share-based compensation (Tables)
9 Months Ended
Sep. 30, 2021
Allocation of compensation expense related to options
The weighted-average grant-date fair value of the options granted in the nine months ended September 30, 2021 and 2020 were $82.21and $34.91 per share, respectively. The Group recorded compensation expense related to the options of $ 19,951 and $ 15,718 for the nine months ended September 30, 2021 and 2020, respectively, which were classified in the accompanying unaudited condensed consolidated statements of operations as follows:
 
    
Three Months Ended September 30,
    
Nine Months Ended September 30,
 
    
2021
    
2020
    
2021
    
2020
 
                             
    
$
    
$
    
$
    
$
 
Selling, general and administrative
     4,119        2,952        11,501        8,500  
Research and development
     3,056        2,411        8,450        7,218  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
     7,175        5,363        19,951        15,718  
    
 
 
    
 
 
    
 
 
    
 
 
 
Allocation of compensation expense related to restricted shares
As of September 30, 2021, there was $46,885 of total unrecognized compensation expense related to
non-vested
restricted shares. The Group recorded compensation expense related to the restricted shares of $8,155 and $4,687 for the nine months ended September 30, 2021 and 2020, respectively, which were classified in the accompanying unaudited condensed consolidated statements of operations as follows:
 
    
Three Months Ended September 30,
    
Nine Months Ended September 30,
 
    
2021
    
2020
    
2021
    
2020
 
                             
    
$
    
$
    
$
    
$
 
Selling, general and administrative
     2,028        1,065        5,078        3,179  
Research and development
     1,353        550        3,077        1,508  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
     3,381        1,615        8,155        4,687